The vaccine contains the two proteins E6 and E7 of HPV 16, which are responsible for a large proportion of cervical cancers, and these peptides are well captured by APCs and presented to CD4+ and CD8+ T cells. The gene discussed is CD8A; the disease is cervical cancer.